The clinical hallmarks of hibernating myocardium include hypocontractility while retaining an inotropic reserve (using dobutamine echocardiography), having normal or increased [ 18 F]fluoro-2-deoxyglucose-6-phosphate ( 18 FDG6P) accumulation associated with decreased coronary flow [flow-metabolism mismatch by positron emission tomography (PET)], and recovering completely postrevascularization. In this study, we investigated an isolated rat heart model of hibernation using experimental equivalents of these clinical techniques. Rat hearts (n ϭ 5 hearts/group) were perfused with Krebs-Henseleit buffer for 40 min at 100% flow and 3 h at 10% flow and reperfused at 100% flow for 30 min (paced at 300 beats/min throughout). Left ventricular developed pressure fell to 30 Ϯ 8% during 10% flow and recovered to 90 Ϯ 7% after reperfusion. In an additional group, this recovery of function was found to be preserved over 2 h of reperfusion. Electron microscopic examination of hearts fixed at the end of the hibernation period demonstrated a lack of ischemic injury and an accumulation of glycogen granules, a phenomenon observed clinically. In a further group, hearts were challenged with dobutamine during the low-flow period. Hearts demonstrated an inotropic reserve at the expense of increased lactate leakage, with no appreciable creatine kinase release. PET studies used the same basic protocol in both dual-and globally perfused hearts (with 250MBq 18 FDG in Krebs buffer Ϯ 0.4 mmol/l oleate). PET data showed flow-metabolism "mismatch;" whether regional or global, 18 FDG6P accumulation in ischemic tissue was the same as (glucose only) or significantly higher than (glucose ϩ oleate) control tissue (0.023 Ϯ 0.002 vs. 0.011 Ϯ 0.002 normalized counts ⅐ s Ϫ1 ⅐ g Ϫ1 ⅐ min Ϫ1 , P Ͻ 0.05) despite receiving 10% of the flow. This isolated rat heart model of acute hibernation exhibits many of the same characteristics demonstrated clinically in hibernating myocardium.hibernation; positron emission topography; isolated heart; dobutamine; morphology UP TO 50% OF ALL PATIENTS suffering from coronary heart disease are thought to have hibernating myocardium that would benefit from revascularization (17, 24). Myocardial hibernation was first described in 1989 by Rahimtoola (28) as the "persistently impaired function of viable myocardium in the setting of reduced coronary blood flow." More recently, however, some patients exhibiting hibernating regions of myocardium have been shown to have near-normal coronary flow. In these patients, it has been suggested that a decreased coronary reserve would lead to successive periods of ischemia and reperfusion, i.e., repetitive stunning (5, 36). However, the presence of normal blood flow during hibernation is not universally accepted (6), and the role of repetitive stunning thus remains the subject of debate (8, 12). Over a decade since the first description of hibernation, little is known about the cellular events involved in its induction and maintenance, and the conditions under which it exists clinically re...